Imaginostics’ CEO, Codi Gharagouzloo, Describes Quantitative Neuroimaging Biomarkers for Precision Medicine at NeuroTech 2020 Meeting

Imaginostics CEO, Codi Gharagouzloo, discussed the Quantitative Neuroimaging Biomarkers for Precision Medicine at the NeuroTech 2020 event, as part of the Neuroimaging and related innovations segment held on December 2nd and 3rd. Other speakers at the event included founders, researchers, and professors. NeuroTech 2020 is described as “the digital congress for neurotechnology innovation and growth,” and it hosted the virtual and interactive conference with several discussions, including segments focused on research, clinical work, longevity, and investments.

Codi Gharagouzloo’s presentation can be viewed here: https://www.eventbrite.com/e/existential-medicine-6-personalized-medicine-tickets-81344618945?aff=ey

Details on the NeuroTech2020 session can be found here: https://www.neurotech2020.com/research